Dabrafenib Mesylate and Recombinate recombinant
Determining the interaction of Dabrafenib Mesylate and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Recombivax
- Dabrafenib Mesylate-Recombivax HB
- Dabrafenib Mesylate-Recombivax HB Adult
- Dabrafenib Mesylate-Recombivax HB Dialysis Formulation
- Dabrafenib Mesylate-Recombivax HB Pediatric/Adolescent
- Dabrafenib Mesylate-Recort Plus
- Recombinate recombinant-Dacarbazine
- Recombinate recombinant-Dacarbazine Intravenous, Injection
- Recombinate recombinant-Daclatasvir
- Recombinate recombinant-Daclatasvir Dihydrochloride
- Recombinate recombinant-Daclizumab
- Recombinate recombinant-Daclizumab Subcutaneous